Cart
sales@molnova.com
Kaempferol 3-neohesperidoside
CAS No. 32602-81-6
Kaempferol 3-neohesperidoside( Kaempferol 3-O-neohesperidoside )
Catalog No. M24260 CAS No. 32602-81-6
Kaempferol 3-neohesperidoside is a flavonoid. Kaempferol 3-neohesperidoside exhibits insulinomimetic effect on the rat soleus muscle.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 161 | In Stock |
|
| 5MG | 123 | In Stock |
|
| 10MG | 187 | In Stock |
|
| 25MG | 315 | In Stock |
|
| 50MG | 461 | In Stock |
|
| 100MG | 644 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKaempferol 3-neohesperidoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionKaempferol 3-neohesperidoside is a flavonoid. Kaempferol 3-neohesperidoside exhibits insulinomimetic effect on the rat soleus muscle.
-
DescriptionKaempferol 3-neohesperidoside is a flavonoid. Kaempferol 3-neohesperidoside exhibits insulinomimetic effect on the rat soleus muscle.
-
In Vitro——
-
In Vivo——
-
SynonymsKaempferol 3-O-neohesperidoside
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorGSK-3|MEK|PI3K
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number32602-81-6
-
Formula Weight594.5
-
Molecular FormulaC27H30O15
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (84.10 mM)
-
SMILESC[C@@H]([C@@H]([C@H]([C@H]1O)O)O)O[C@H]1O[C@H]([C@H]1O)[C@H](OC2=C(c(cc3)ccc3O)Oc(cc(cc3O)O)c3C2=O)O[C@H](CO)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Insulinomimetic effect of kaempferol 3-neohesperidoside on the rat soleus muscle.J Nat Prod. 2008 Apr;71(4):532-5.
molnova catalog
related products
-
GSK3-IN-4
GSK3-IN-4 is a GSK-3 inhibitor with IC50 of 0.101-1 μM of GSK-3α and GSK-3β in Calipe Assay.
-
IM-12
IM-12 is a novel potent GSK-3β inhibitor with IC50 of 53 nM, significantly increases the β-catenin level and activates canonical Wnt signalling.
-
TDZD-8
A potent, selective, non-ATP competitive GSK-3β inhibitor with IC50 of 2 uM; displays no activity against PKA, CK-2, PKC, and CDK1 (IC50>100 uM).
